142102-28-1

Upstream product

• 72409-20-2 N⁴-benzoyl-5'-O-(tert-butyldimethylsilyl)cytidine 
• 74-88-4 methyl iodide 

Downstream Products

• 142068-16-4 N⁴-benzoyl-5'-O-(tert-butyldimethylsilyl)-2',3'-didehydro-2',3'-dideoxycytidine 
• 123413-57-0 N⁴-benzoyl-2',3'-didehydro-2',3'-dideoxycytidine 
• 142068-18-6 N⁴-benzoyl-2',3'-didehydro-2',3'-dideoxycytidine 5'-dimethyl phosphate 
• 142068-05-1 Phenyl-phosphonic acid mono-[(2S,5R)-5-(4-amino-2-oxo-2H-pyrimidin-1-yl)-2,5-dihydro-furan-2-ylmethyl] ester; compound with ammonia 
• 142068-06-2 Phenyl-phosphonothioic acid O-[(2S,5R)-5-(4-amino-2-oxo-2H-pyrimidin-1-yl)-2,5-dihydro-furan-2-ylmethyl] ester; compound with ammonia 
• 142068-08-4 Phosphoric acid (2S,5R)-5-(4-amino-2-oxo-2H-pyrimidin-1-yl)-2,5-dihydro-furan-2-ylmethyl ester phenyl ester; compound with ammonia 

Relevant academic research and scientific papers

Potential prodrug derivatives of 2',3'-didehydro-2',3'-dideoxynucleosides. Preparations and antiviral activities

The preparations and antiviral activities of a series (4-17) of potential prodrug forms of the antivirals 2',3'-didehydro-2',3'-dideoxyadenosine (D4A) and 2',3'-didehydro-2',3'-dideoxycytosine (D4C) are reported. The 5'-phenyl and 5'-methylphosphonates (4